1. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival
   Thomas J. Smith et al, 2002, Journal of Clinical Oncology CrossRef
2. Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
   Christina Fotopoulou et al, 2008, Journal of Clinical Oncology CrossRef
3. Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery
   Marisa Market et al, 2021, International Journal of Molecular Sciences CrossRef
4. Anticoagulation during continuous renal replacement therapy: An update
   Theodoros Aslanidis et al, 2019, Serbian Journal of Anesthesia and Intensive Therapy CrossRef
5. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
   Marisa Market et al, 2018, Cancers CrossRef
6. Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
   Ajay K. Kakkar et al, 2004, Journal of Clinical Oncology CrossRef